Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,760,101 papers from all fields of science
Search
Sign In
Create Free Account
Efflumidex
Known as:
Pharm Allergan Brand of Fluorometholone
, Pharm-Allergan Brand of Fluorometholone
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Fluorometholone
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Low Incidence of Clean Intermittent Catheterisation With OnabotulinumtoxinA in Diverse Age Groups of Overactive Bladder Patients With Corresponding Improvements in Urinary Symptoms, Treatment…
V. Nitti
,
M. Drake
,
+7 authors
C. Chapple
2017
Corpus ID: 79497486
Nitti V1, Drake M2, Everaert K3, Rovner E4, Dmochowski R5, Ginsberg D6, Radomski S7, Aboushwareb T8, Chang C9, Chapple C10 1. New…
Expand
Review
2016
Review
2016
Temporomandibular Joint Fibrous Ankylosis – A Case Report
Chetan Bhat
,
Smita Patil
,
Natasha Kale
,
N. Salunkhe
2016
Corpus ID: 21175728
Temporomandibular joint is unique, complex, synovial joint of the jaw playing a vital role in opening and closing movements of…
Expand
Review
2016
Review
2016
Himachal Institute of Pharmacy
Paonta Sahib
2016
Corpus ID: 54005743
Research on granulation processes has concentrated on the use of mechanical mixers. Understanding of the mechanisms by which…
Expand
2015
2015
Quantitative Analysis of Ambroxol Hydrochloride and Loratadine in Bulk and Pharmaceutical Formulations
P. Arumugam
2015
Corpus ID: 105551587
INTRODUCTION: Everything made by human hands is subject to decay. Pharmaceuticals are no exception to this. A drug for oral use…
Expand
2014
2014
Actavis, Allergan CEOs talk acquisition
Colleen E. McCarthy
2014
Corpus ID: 70876006
“The future is as bright as it’s ever been as a combined company—we’ll have an incredible amount of resources,” says Actavis CEO…
Expand
2013
2013
mRCC: Bei vergleichbarer Wirkung entscheidet die Lebensqualität
S. Lux
Uro-News
2013
Corpus ID: 33210191
— Am 31. Januar 2013 hat das Unternehmen Allergan für Botulinumtoxin Typ A (Botox®) die Zulassung zur Behandlung der idiopathisch…
Expand
2013
2013
Using SAS® Enterprise Guide®: A System Administrator's Perspective
Haibo Jiang
,
S. Shiue
,
T. Barbour
,
R. Stevens
2013
Corpus ID: 62455173
With the implementation of SAS Intelligence Platform, and the promotion of SAS Enterprise Guide as the main Statistical…
Expand
2013
2013
Neue Zulassung von Botulinumtoxin Typ A zur Behandlung der überaktiven Blase
Prisma Pharmaforum
Uro-News
2013
Corpus ID: 28375885
— Am 31. Januar 2013 hat das Unternehmen Allergan für Botulinumtoxin Typ A (Botox®) die Zulassung zur Behandlung der idiopathisch…
Expand
2013
2013
Latin American Consensus on Age-Related Macular Degeneration
F. Rodríguez
2013
Corpus ID: 71026102
Age-related macular degeneration (AMD) is a chronic disease affecting the retina and is the most common cause of blindness in the…
Expand
2004
2004
Klinisch-toxikologische Zusammenstellung der Vergiftungsfälle in Florenz im Triennium 1950–1952
Giuliano Abbozzo
Fühner-Wieland's Sammlung von Vergiftungsfällen
2004
Corpus ID: 40929787
u. E. Jacobsen: Acta pharm, et tox. 4, 305 (1948); Lancet II, 1001 (1948). Hald, J. u. V. Larsen: Acta pharm, et tox. 8, 292…
Expand